Measles ( rubeola) virus qualitative real-time reverse transcription–polymerase chain reaction assay: development and clinical validation on an automated workflow
Laboratory Medicine · 05.10.2026 · 57 (6)
DOI: 10.1093/labmed/lmag075 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Laboratory Medicine, online erschienen am 09.10.2026. Verfasst von Lan Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States. Hauptthemen laut MEDLINE: Measles virus, Measles, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Professorship in Biomedical Science.
Abstract (Originalsprache)
Introduction
Detection of Measles virus (MeV) RNA is an important method for confirming infection. This study described the clinical validation of a qualitative real-time reverse transcriptase–polymerase chain reaction (RT-PCR) assay for MeV detection.
Methods
A real-time RT-PCR assay was developed and validated using primers and probes previously reported in the literature. The assay was evaluated using reference materials, cultured virus, and previously tested clinical throat swab samples. An automated workflow was established for RNA extraction, RT-PCR amplification, and result reporting using robotic platforms and a real-time PCR instrument. The assay targets the measles nucleoprotein (N) and hemagglutinin (H) genes, with human RNase P gene used as an internal control.
Results
The MeV RT-PCR assay has a limit of detection of 500 genome copies per milliliter. The assay was tested against 85 different samples: 50 positive clinical samples and reference materials and 35 negative clinical samples or reference materials. All expected results were correctly identified, giving 100% sensitivity (50/50) and specificity (35/35). The assay showed 100% interassay and intra-assay reproducibility. No cross-reactivity was observed with other respiratory viruses or common bacterial and fungal pathogens.
Discussion
This automated measles RT-PCR assay demonstrated high accuracy, sensitivity, specificity, and reproducibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, United States.
ORCID-Profile: Jason Y Park
Förderung
- Professorship in Biomedical Science
Zitieren
APA
Yu, L., Chen, L., Dumas, K., Weyandt, N., Meyers, M., Irwin, P., Eitson, J. L., Schoggins, J. W., & Park, J. Y. (2026). Measles ( rubeola) virus qualitative real-time reverse transcription–polymerase chain reaction assay: development and clinical validation on an automated workflow. Laboratory Medicine, 57(6). https://doi.org/10.1093/labmed/lmag075
Vancouver
Yu L, Chen L, Dumas K, Weyandt N, Meyers M, Irwin P, et al. Measles ( rubeola) virus qualitative real-time reverse transcription–polymerase chain reaction assay: development and clinical validation on an automated workflow. Laboratory Medicine. 2026;57(6). doi:10.1093/labmed/lmag075
BibTeX
@article{Yu2026,
author = {Yu, Lan and Chen, Li and Dumas, Kevin and Weyandt, Nickolas and Meyers, Michael and Irwin, Pei and Eitson, Jennifer L and Schoggins, John W and Park, Jason Y},
title = {Measles ( rubeola) virus qualitative real-time reverse transcription–polymerase chain reaction assay: development and clinical validation on an automated workflow},
journal = {Laboratory Medicine},
year = {2026},
volume = {57},
number = {6},
doi = {10.1093/labmed/lmag075}
}
EUVIMED